Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | +1.12% | -7.65% | -48.32% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.12M 343M |
---|---|---|---|---|---|
Net income 2024 * | -16M -1.33B | Net income 2025 * | -21M -1.75B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.4
x | P/E ratio 2025 * |
-0.37
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.41% |
Latest transcript on TRACON Pharmaceuticals, Inc.
1 day | +1.12% | ||
1 week | -7.65% | ||
Current month | -78.94% | ||
1 month | -77.93% | ||
3 months | -56.28% | ||
6 months | -44.07% | ||
Current year | -48.32% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 01/06/01 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 01/15/01 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 26/14/26 |
Director/Board Member | 54 | 19/20/19 | |
Stephen Worland
BRD | Director/Board Member | 66 | 25/15/25 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.81 | +1.12% | 206,653 |
25/24/25 | 1.79 | -5.29% | 131,052 |
24/24/24 | 1.89 | +2.16% | 65,903 |
23/24/23 | 1.85 | +1.65% | 55,123 |
22/24/22 | 1.82 | -7.14% | 143,958 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.32% | 4.12M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- TCON Stock